Prediction of total hospital expenses of patients undergoing breast cancer surgery in Shanghai, China by comparing three models

Author:

Chen Minjie,Wu Xiaopin,Zhang Jidong,Dong Enhong

Abstract

Abstract Background Breast cancer imposes a considerable burden on both the health care system and society, and becomes increasingly severe among women in China. To reduce the economic burden of this disease is crucial for patients undergoing the breast cancer surgery, hospital managers, and medical insurance providers. However, few studies have evidenced the prediction of the total hospital expenses (THE) for breast cancer surgery. The aim of the study is to predict THE for breast cancer surgery and identify the main influencing factors. Methods Data were retrieved from the first page of medical records of 3699 patients undergoing breast cancer surgery in one tertiary hospital from 2017 to 2018. Multiple liner regression (MLR), artificial neural networks (ANNs), and classification and regression tree (CART) were constructed and compared. Results The dataset from 3699 patients were randomly divided into training and test sets at a 70:30 ratio (2599 and 1100 records, respectively). The average total hospital expenses were 12520.54 ± 7844.88 ¥ (US$ 1929.20 ± 1208.11). MLR results revealed six factors to be significantly associated with THE: age, LOS, type of disease, having medical insurance, minimally invasive surgery, and receiving general anesthesia. After comparing three models, ANNs was the best model to predict THEs in patients undergoing breast cancer surgery, and its strong predictive performance was also validated. Conclusions To reduce the THEs, more attention should be paid to related factors of LOS, major and minimally invasive surgeries, and general anesthesia for these patient groups undergoing breast cancer surgery. This may reduce the information asymmetry between doctors and patients and provide more reliable cost, practical inpatient medical consumption standards and reimbursement standards reference for patients, hospital managers, and medical insurance providers ,respectively.

Publisher

Springer Science and Business Media LLC

Subject

Health Policy

Reference52 articles.

1. McKinney SM, et al. International evaluation of an AI system for breast cancer screening. Nature. 2020;577(7788):89–94.

2. Dalfardi B, Mahmoudi NG, Tahmasebi S. Highlights in the diagnosis of breast neoplasms. Acta Med Hist Adriat. 2015;13(2):427–40.

3. Fan L, Strasser-Weippl K, Li J, St Louis J, Finkelstein DM, Yu K, et al. Breast cancer in China. The Lancet. 2014;15(7):e279–89.

4. Yin XJ, Xu Y, Man XW, Liu LM, Jiang Y, Zhao LY, et al. Direct costs of both inpatient and outpatient care for all type cancers: The evidence from Beijing. China. Cancer Med. 2019;8(6):3250–60.

5. Huang Y, Tong Z, Chen K, Wang Y, Liu P, Gu L, et al. Interpretation of breast cancer screening guideline for Chinese women. Cancer biology & medicine. 2019;16(4):825.

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3